2006

Established our first manufacturing plant in Baddi, Himachal Pradesh

2010

Commenced operations at the new manufacturing facility (Cephalosporin) at Baddi, Himachal Pradesh. Crucial expansion in the Company’s manufacturing capabilities.

2013

Received first international accreditation, the Certificate of Good Manufacturing Practices (GMP) for cephalosporin products from the Ministry of Medical Services, Republic of Kenya.

2015

Incorporated Univentis Medicare Limited for strengthening the Company’s marketing operations and market presence.

2017

Commenced operations at new manufacturing facility (General) in Baddi, Himachal Pradesh.

2021

Expanded manufacturing capabilities of the General block to achieve current capacity levels.

2022

Commenced construction of a new greenfield manufacturing plant in Kathua, Jammu and Kashmir.

Commenced construction of Research and Development center in Panchkula, Haryana.

2023

Acquired Sharon Bio-Medicine Limited through the Corporate Insolvency Resolution Process (CIRP) to further strengthen our pharmaceutical portfolio.

Listed on India Stock Exchanges (NSE and BSE) on December 29, 2023.